Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 4/20 | 0.34 |
| ▸ | MMP13 | P45452 | 4/20 | 0.34 |
| ▸ | MMP1 | P03956 | 3/20 | 0.34 |
| ▸ | MMP3 | P08254 | 3/20 | 0.34 |
| ▸ | MMP9 | P14780 | 3/20 | 0.34 |
| ▸ | MMP7 | P09237 | 2/20 | 0.34 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19545557 | 0.87 | MME (0.39) | MMEACECPA1ACE2ADAM17 | |
| SCHEMBL21676278 | 0.82 | CA12 (0.39) | CA12CA14ADAM17CA2CA1 | |
| SCHEMBL5839741 | 0.80 | KDM4E (0.49) | CA12CA14KDM4EMMP2MMP13 | |
| SCHEMBL5839738 | 0.80 | KDM4E (0.49) | CA12CA14KDM4EMMP2MMP13 | |
| SCHEMBL24642687 | 0.76 | MME (0.44) | MMEACECPA1ACE2LTA4H | |
| SCHEMBL25628538 | 0.76 | MME (0.44) | MMEACECPA1ACE2LTA4H | |
| SCHEMBL25993488 | 0.76 | MME (0.44) | MMEACECPA1ACE2LTA4H | |
| SCHEMBL17305532 | 0.76 | MME (0.44) | MMEACECPA1ACE2LTA4H | |
| SCHEMBL18047580 | 0.75 | ADAMTS4 (0.44) | MMEACECPA1ACE2CA12 | |
| SCHEMBL697449 | 0.75 | ADAMTS4 (0.44) | MMEACECPA1ACE2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590273-B2 | Stabilized glycoside hydrolase variants | NOVOZYMES A/S (DK) | 2026-03-31 | — | — | US | disclosed |
| US-12391934-B2 | Stabilized cellulase variants | NOVOZYMES A/S (DK) | 2025-08-19 | — | — | US | disclosed |
| US-20250084394-A1 | STABILIZED CELLULASE VARIANTS | NOVOZYMES A/S (DK) | 2025-03-13 | — | — | US | disclosed |
| US-12129498-B2 | Stabilized endoglucanase variants | NOVOZYMES A/S (DK) | 2024-10-29 | — | — | US | disclosed |
| US-20230295591-A1 | STABILIZED CELLULASE VARIANTS | NOVOZYMES A/S (DK) | 2023-09-21 | — | — | US | disclosed |
| US-20230287380-A1 | STABILIZED CELLULASE VARIANTS | NOVOZYMES A/S (DK) | 2023-09-14 | — | — | US | disclosed |
| US-11661592-B2 | Stabilized endoglucanase variants | NOVOZYMES A/S (DK) | 2023-05-30 | — | — | US | disclosed |
| US-20230143128-A1 | CARBOHYDRATE BINDING MODULE VARIANTS | NOVOZYMES A/S (DK) | 2023-05-11 | — | — | US | disclosed |
| US-11566239-B2 | Stabilized cellulase variants | NOVOZYMES A/S (DK) | 2023-01-31 | — | — | US | disclosed |
| US-20220186151-A1 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | NOVOZYMES A/S (DK) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143128-A1 | CARBOHYDRATE BINDING MODULE VARIANTS | MGAM, MANBA, MAN2B1 | MME 139/4885ACE 990/4885CPA1 172/4885 |
| US-12590273-B2 | Stabilized glycoside hydrolase variants | IDUA, IDE, TREH | MME 542/4885ACE 922/4885CPA1 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.